Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.

Rigouts L, Hoza AS, De Rijk P, Torrea G, Chonde TM, Basra D, Zignol M, van Leth F, Egwaga SM, Van Deun A.

Int J Tuberc Lung Dis 2011;15(7):959-65.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/21682972

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us